GT Medical Technologies, a company focused on supporting patients with brain tumors, has announced that Rush University Medical Center has been named the latest GammaTile Center of Excellence. This designation highlights hospitals and doctors who lead in brain tumor treatment and have shown strong skills in using GammaTile technology effectively.
Health Technology Insights: ZOIA Healthcare Acquires Lil’s Dietary a Commitment to Rare Metabolic Disease Community
To receive this honor, physicians and their institutions must meet strict clinical standards, perform a certain number of GammaTile procedures each year, and continue to stay up to date with training. At Rush, the following physicians have been recognized: Dr. Stephan Munich, neurosurgeon; Dr. Lorenzo F. Muñoz, neurosurgeon; and Dr. Ken Tatebe, radiation oncologist. Dr. Tatebe, who also serves as Associate Professor of Radiation Oncology and Neurological Surgery at Rush University Medical Center, said, “GammaTile has given us a new way to treat brain tumors, giving our patients more options. We are proud to be recognized as a GammaTile Center of Excellence as part of our commitment to improving care by using new treatment technologies.”
Health Technology Insights: Surgical Safety Tech Adds Kinematic Data to Boost Proficiency
GammaTile therapy is a form of radiation treatment applied during surgery to remove brain tumors. The technique delivers focused radiation to the tumor area at the time of surgery, when cancer cells are at their weakest. Unlike traditional methods that require a delay before starting radiation, GammaTile allows treatment to begin immediately. This approach reduces the chance of tumor regrowth and improves patient outcomes.
The recognition of Rush University Medical Center as a GammaTile Center of Excellence reflects the value of adopting innovative approaches in brain tumor care. It also shows how healthcare institutions can raise the bar for treatment by embracing advanced solutions like GammaTile that provide more effective care options close to the time of surgery.
Health Technology Insights: C8 Health Raises $12 Million Series A for the Healthcare Industry’s First AI-Powered
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
